EPISODE · Oct 27, 2017 · 10 MIN
New Science Could Sharpen Crispr's Gene-Editing Scalpel
from Science, Spoken · host SpokenLayer
Stay on target. That’s the mantra you hear in labs and biotech companies around the world as they snip away at DNA. All the techniques for gene editing—from the famous Crispr-Cas9 to the older TALENs and zinc-finger nucleases—share a problem: Sometimes they don’t work. Which is to say, they have “off-target effects,” changing a gene you don’t want changed or failing to change a gene that you do. And DNA is not something you want poorly rewired. Learn about your ad choices: dovetail.prx.org/ad-choices
What this episode covers
Stay on target. That’s the mantra you hear in labs and biotech companies around the world as they snip away at DNA. All the techniques for gene editing—from the famous Crispr-Cas9 to the older TALENs and zinc-finger nucleases—share a problem: Sometimes they don’t work. Which is to say, they have “off-target effects,” changing a gene you don’t want changed or failing to change a gene that you do. And DNA is not something you want poorly rewired.
NOW PLAYING
New Science Could Sharpen Crispr's Gene-Editing Scalpel
No transcript for this episode yet
Similar Episodes
No similar episodes found.